Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Gad Soffer currently holds 243,966 shares of Atara Biotherapeutics, Inc. (ATRA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gad Soffer has been a net seller of ATRA stock. They have purchased $0 and sold $2.5M worth of shares.
Gad Soffer's most recent insider trade was on Sep 22, 2018, when they sold 22,158 shares at $39.85 per share.
Gad Soffer serves as Executive at Atara Biotherapeutics, Inc. (ATRA). They have executed 56 insider transactions totaling $2.5M over their tenure at the company.
Gad Soffer holds the position of Executive at Atara Biotherapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 11 years and currently hold a stake valued at $0.
Gad Soffer has shown a selling trading pattern, with $0 in total purchases and $2.5M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Gad Soffer was on Sep 22, 2018, when they sold $883.0K worth of ATRA shares. This transaction involved 22,158 shares at $39.85 per share.
Gad Soffer currently owns 243,966 shares of Atara Biotherapeutics, Inc. (ATRA), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Gad Soffer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Gad Soffer has 56 Form 4 filings on record as an insider at Atara Biotherapeutics, Inc..
Set alerts for Gad Soffer and 40,000+ other insiders.